Evidence map›Paper›PMID 30834109›Full record

ArticleCell & bioscience2019

Myopia disease mouse models: a missense point mutation (S673G) and a protein-truncating mutation of the

Katarzyna I Szczerkowska, Silvia Petrezselyova, Jiri Lindovsky, Marcela Palkova, Jan Dvorak, Peter Makovicky, Mingyan Fang, Chongyi Jiang, Lingyan Chen, Mingming Shi and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. eLife · 2025
    Article
  4. Insights into Myopia from Mouse Models.Annual review of vision science · 2024
    Review
  5. Article
  6. Mice LackingInternational journal of molecular sciences · 2022
    Article
  7. Review
  8. IMI 2021 Yearly Digest.Investigative ophthalmology & visual science · 2021
    Review
  9. Animal modeling for myopia.Advances in ophthalmology practice and research
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 4 countries.

Katarzyna I Szczerkowska1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics CAS, Prumyslova 595, Vestec, 252 50 Prague, Czech Republic.
Silvia Petrezselyova1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics CAS, Prumyslova 595, Vestec, 252 50 Prague, Czech Republic.
Jiri Lindovsky2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Marcela Palkova2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Jan Dvorak1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics CAS, Prumyslova 595, Vestec, 252 50 Prague, Czech Republic.
Peter Makovicky2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Mingyan Fang3Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Chongyi Jiang4BGI-Shenzhen, Shenzhen, 518083 China.
Lingyan Chen4BGI-Shenzhen, Shenzhen, 518083 China.
Mingming Shi4BGI-Shenzhen, Shenzhen, 518083 China.
Xiao Liu4BGI-Shenzhen, Shenzhen, 518083 China.
Jianguo Zhang4BGI-Shenzhen, Shenzhen, 518083 China.
Agnieszka Kubik-Zahorodna2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Bjoern Schuster2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Inken M Beck2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Vendula Novosadova2Czech Centre for Phenogenomics, Institute of Molecular Genetics CAS, Prague, Czech Republic.
Jan Prochazka1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics CAS, Prumyslova 595, Vestec, 252 50 Prague, Czech Republic.
Radislav Sedlacek1Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics CAS, Prumyslova 595, Vestec, 252 50 Prague, Czech Republic.ORCID 0000-0002-3352-392X
Czech Academy of Sciences, Institute of Molecular Genetics · CZBGI Group (China) · CNUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc finger 644 (Zfp644 in mouse, ZNF644 in human) gene is a transcription factor whose mutation S672G is considered a potential genetic factor of inherited high myopia. ZNF644 interacts with G9a/GLP complex, which functions as a H3K9 methyltransferase to silence transcription. In this study, we generated mouse models to unravel the mechanisms leading to symptoms associated with high myopia. Employing TALEN technology, two mice mutants were generated, either with the disease-carrying mutation (

Indexed as

EyeGeneticsMouse modelMyopiaVisionZinc finger 644

Identifiers

PMID30834109
PMCPMC6385473
OpenAlexW2922466572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.